Hybrid Conferencee

International Conference on Biochemical Pharmacology and Toxicology (ICBPT - 27)

23rd - 24th June 2027 | Teresina, Brazil
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 23–24 June 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 5 SDGs SDGs 3, 4, 9, 10 and 12
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

23 JUN 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Biochemical Pharmacology
    34
    Track Overview

    This track focuses on the latest developments in biochemical pharmacology, emphasizing novel drug design and optimization strategies. Participants will explore innovative methodologies for enhancing drug efficacy and safety profiles.

    Track 02
    Molecular Mechanisms of Drug Metabolism
    39
    Track Overview

    This session delves into the intricate molecular mechanisms underlying drug metabolism, highlighting key enzymes and pathways involved. Discussions will center on the implications of these processes for pharmacokinetics and pharmacodynamics.

    Track 03
    Enzyme Inhibition and Drug Interaction
    39
    Track Overview

    This track examines the role of enzyme inhibition in drug interactions and its impact on therapeutic outcomes. Researchers will present findings on how enzyme modulation can alter drug efficacy and safety.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Toxicological Modeling and Risk Assessment
    312
    Track Overview

    This session addresses the latest advancements in toxicological modeling techniques and their application in risk assessment. Participants will discuss methodologies for predicting adverse effects and establishing safety thresholds.

    Track 05
    Cellular Toxicity and Bioassays
    312
    Track Overview

    This track focuses on the assessment of cellular toxicity through innovative bioassays. Researchers will present their findings on the development and validation of in vitro models for evaluating toxicological effects.

    Track 06
    Receptor Binding and Drug Design
    39
    Track Overview

    This session explores the significance of receptor binding in the context of drug design and development. Participants will discuss strategies for optimizing receptor-ligand interactions to enhance therapeutic efficacy.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
View Day 02 Schedule →
Day 02

Keynote, Technical Sessions & Awards

24 JUN 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Pharmacogenomics and Personalized Medicine
    310
    Track Overview

    This track highlights the role of pharmacogenomics in tailoring drug therapies to individual genetic profiles. Discussions will focus on how genetic variations influence drug metabolism and response.

    Track 08
    Molecular Toxicology and Chemical Interactions
    312
    Track Overview

    This session investigates the molecular basis of toxicological responses to chemical exposures. Participants will explore the interactions between chemicals and biological systems at the molecular level.

    Track 09
    Therapeutic Targets in Drug Development
    39
    Track Overview

    This track focuses on identifying and validating therapeutic targets for drug development. Researchers will present novel approaches to target discovery and the implications for treatment strategies.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Adverse Drug Reactions: Mechanisms and Management
    310
    Track Overview

    This session addresses the mechanisms underlying adverse drug reactions and their clinical implications. Participants will discuss strategies for predicting, preventing, and managing these reactions in clinical practice.

    Track 11
    Toxicogenomics: Bridging Genomics and Toxicology
    39
    Track Overview

    This track explores the integration of genomics into toxicological research, emphasizing the role of toxicogenomics in understanding chemical-induced toxicity. Discussions will focus on how genomic data can inform risk assessment and regulatory decisions.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
← Back to Day 01 Schedule
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities 12 Responsible Consumption and Production

Be Part of ICBPT-27

Submit your research or complete your conference registration.

Submit Abstract / Paper Complete Registration
Copyrights © . All Rights Reserved. Terms & Conditions